The simultaneous targeting of (invading) tumor cells as well as tumor stromal cells by a uPAR-specific probe increases the percentage of tumor mass that will be targeted and would make uPAR a pluripotent tumor target, applicable for a broad range of tumor types (66–68). This evidence concerns the gene PLAUR and neoplasm.